Back

Lilly's EBGLYSS Phase 3b data show rapid improvements in atopic dermatitis

Verifying
  • Lilly's EBGLYSS delivered improvements across several measures of hand and foot atopic dermatitis.
  • Phase 3b findings showed rapid gains in skin clearance, itch, pain and satisfaction.
  • Participants had moderate-to-severe hand and foot atopic dermatitis.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.